reboxetine has been researched along with Narcolepsy in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fendt, M; Leibiger, J; Schmidt, C | 1 |
| Gonzalez-Arriaza, HL; Krahn, LE | 1 |
| Bario, S; de la Llave, Y; Garcia-Borreguero, D; Granizo, JJ; Larrosa, O | 1 |
3 other study(ies) available for reboxetine and Narcolepsy
| Article | Year |
|---|---|
The norepinephrine reuptake inhibitor reboxetine is more potent in treating murine narcoleptic episodes than the serotonin reuptake inhibitor escitalopram.
Topics: Adrenergic Uptake Inhibitors; Animals; Citalopram; Disease Models, Animal; Dose-Response Relationship, Drug; Electroencephalography; Electromyography; Locomotion; Mice; Mice, Inbred C57BL; Mice, Transgenic; Morpholines; Narcolepsy; Orexins; Reboxetine; Selective Serotonin Reuptake Inhibitors; Time Factors | 2016 |
Narcolepsy with cataplexy.
Topics: Adult; Cataplexy; Comorbidity; Cyclohexanols; Hallucinations; Humans; Male; Morpholines; Narcolepsy; Patient Education as Topic; Reboxetine; Selective Serotonin Reuptake Inhibitors; Sodium Oxybate; Venlafaxine Hydrochloride | 2004 |
Stimulant and anticataplectic effects of reboxetine in patients with narcolepsy: a pilot study.
Topics: Adult; Antidepressive Agents; Cataplexy; Female; Humans; Male; Morpholines; Narcolepsy; Pilot Projects; Reboxetine; Severity of Illness Index; Sleep Stages | 2001 |